Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 457

Results For "MS"

5450 News Found

Healthium collaborates with Abhinav Bindra to treat sports injuries
Healthcare | March 06, 2022

Healthium collaborates with Abhinav Bindra to treat sports injuries

According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport


Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
Drug Approval | March 06, 2022

Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens

Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category


Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol


Oragenics announces positive data on Covid-19 intranasal vaccine
Biotech | March 04, 2022

Oragenics announces positive data on Covid-19 intranasal vaccine

Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters


WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
Biotech | March 04, 2022

WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site

WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms


WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
News | March 04, 2022

WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements


Known Medicine partners with Duke University to predict lung cancer response to drug treatments
Biotech | March 04, 2022

Known Medicine partners with Duke University to predict lung cancer response to drug treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer


AIkido Pharma improves manufacturing process for pancreatic drug
Biotech | March 04, 2022

AIkido Pharma improves manufacturing process for pancreatic drug

The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug


USFDA issues final guidance on voluntary recalls
News | March 04, 2022

USFDA issues final guidance on voluntary recalls

The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem


AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio
News | March 04, 2022

AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio

Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies